Shares of Theravence (THRX -33.4%) crater after the firm's Phase III results for Relovair...

|By:, SA News Editor

Shares of Theravence (THRX -33.4%) crater after the firm's Phase III results for Relovair (previous) includes the disclosure of pneumonia-related deaths in patients.